![]() |
市场调查报告书
商品编码
1642609
全球肠内营养配方市场:成长、未来展望与竞争分析(2024-2032 年)Enteral Feeding Formulas Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032 |
肠内营养市场包括当口服摄取不足、无法摄取或不安全时透过消化道输送给患者的各种营养解决方案。这种营养支持方法用于各种医疗保健环境,包括医院、长期照护机构和家庭护理。肠内营养是临床营养的重要组成部分,特别适用于慢性疾病患者、手术患者以及营养不良患者。这些肠内营养配方市场的发展受到全球慢性病盛行率上升、配方改善和老年人口成长的推动。预测期内,即 2024-2032 年,肠内营养製剂市场预计将以 7.2% 的复合年增长率成长。
肠内营养配方市场推动因素
慢性病和营养不良发生率上升
癌症、糖尿病和神经系统疾病等慢性疾病的发生率不断上升,导致患者难以维持足够的口服摄取量,这是肠内营养製剂市场发展的主要驱动力。这些配方提供的强化营养有助于控制疾病症状,支持康復并改善患者的整体生活品质。医院和长期照护机构扩大采用肠内营养作为治疗营养不良和疾病相关体重减轻的标准治疗方法,进一步推动了对这些产品的需求。
餵食配方和设备的技术进步
肠内营养产品配方和输送方面的重大技术进步正在扩大其用途和效率。针对特定疾病(如肾衰竭或肺部疾病)患者的独特营养需求而开发的特定疾病配方,改善了患者的治疗效果和营养治疗的依从性。营养输送系统的技术创新,例如能够实现精确和安全营养输送的可编程泵,也促进了市场的成长。这些技术进步提高了餵食配方的适口性、吸收性和有效性,从而被各种医疗保健和家庭护理环境广泛采用。
世界人口老化
全球老年人口不断增长,更容易患慢性疾病和吞嚥困难,大大推动了肠内营养产品的需求。老年患者通常需要长期营养管理来维持健康并控制与老化相关的生理变化。肠内营养由于使用方便、可在家中进行而成为老年护理的首选,从而支持了该领域市场的持续增长。
制约肠内营养製剂市场的因素
肠内营养相关併发症
儘管肠内营养製剂有许多好处,但其市场却因管饲相关併发症而受到严重限制。管子移位、感染以及腹泻和便秘等胃肠道併发症等问题可能会阻碍肠内营养的使用。这些併发症需要仔细监测和管理,从而增加了整体医疗保健成本以及临床医生和护理人员的负担。吸入性和由此引发的肺炎的风险也会带来严重的健康风险,尤其是对于老年和重症患者。这项课题影响了医疗保健提供者的肠内营养采用率,他们必须平衡肠内营养的好处和潜在的副作用。管理这些风险的复杂性,再加上需要对护理人员和医疗保健专业人员进行管饲技术的专门培训,在一定程度上限制了市场的成长潜力。
按产品细分市场
肠内营养製剂市场依产品细分为标准製剂、特定疾病製剂、元素製剂、半元素製剂及其他製剂。针对特定疾病的配方药物预计将呈现最高的复合年增长率(CAGR),因为它们针对性地治疗肾臟疾病、呼吸系统疾病和糖尿病等特定临床状况。这些配方旨在满足这些疾病的特定营养需求和限制,改善患者的治疗效果和依从性。同时,标准配方预计将在市场上创造最高的收入。这些配方广泛用于一般用途,为没有特定饮食限製或特殊营养需求的患者提供均衡的营养。标准化配方是从医院到家庭护理等各种医疗环境中肠内营养的基本组成部分,并且已成为肠内营养产业的主力。这些产品的广泛使用以及肠内营养作为常规临床护理一部分的日益被接受,为该领域带来了可观的收入。
按阶段划分市场
在肠内营养製剂市场中,按阶段细分包括成人患者和儿科患者。预计儿科领域将实现最高的复合年增长率,因为在早期发育阶段迫切需要适当的营养,以及影响口服摄入的儿童疾病和病症(如发育迟缓、脑性麻痹和囊性纤维化)的发病率不断上升。儿科配方奶粉是专门为满足儿童的营养需求而设计的,考虑了儿童的生长需求和代谢率。相较之下,由于大量成年患者需要肠内营养,成人市场占了最高收入。其中包括患有慢性疾病的老年患者、手术后復健患者、残疾成年人和接受安宁疗护的患者。全球老龄化人口不断增长以及需要长期营养管理的慢性病的盛行推动了成人市场在销售中的主导地位,从而确保了对成人专用肠内营养製剂的持续需求。
肠内营养配方市场的区域细分
根据肠内营养製剂市场的地理趋势,北美目前在收入方面处于领先地位,这得益于先进的医疗基础设施、高昂的医疗支出以及需要临床营养解决方案的慢性病患病率的不断上升。此外,该地区严格的监管标准和对肠内营养益处的高度认识继续主导着市场。同时,亚太地区预计在 2024 年至 2032 年期间的复合年增长率 (CAGR) 最高。这种快速增长的动力是人口老化不断增长,尤其是在日本和中国等国家,以及医疗支出的增加和医疗基础设施的改善。这些地区医院的扩张和需要营养管理的疾病的盛行率增加也是加速市场成长的关键因素。此外,政府改善病患治疗效果的措施和家庭医疗保健服务的日益普及,增加了亚太地区对肠内营养解决方案的需求,使其成为全球快速扩张的市场。
肠内营养製剂市场的竞争趋势
肠内营养製剂市场的竞争格局包括Abbott Laboratories、B. Braun Melsungen AG、Baxter International、Danone S.A.、Fresenius Kabi、Functional Formularies、Hormel Health Labs、Kate Farms、Medtrition、Meiji Holdings、Nestle、NutriMedical、Real Food Blends、Vegenat Healthcare、Victus等主要参与者。这些公司透过持续创新和策略举措来帮助塑造市场动态。2022年,Nestle、Abbott Laboratories等主要参与者凭藉多元化的产品组合和强大的全球分销网络实现了强劲的收入。从 2024 年到 2032 年,这些主要参与者预计将专注于扩大其地理覆盖范围并增强其产品供应,以满足不同患者群体的特定营养需求。随着企业寻求扩大实力并进入新兴市场,策略併购预计将变得更加普遍。此外,预计还将增加对研发的投资,重点开发针对各种医疗状况的更专业、更针对疾病的配方。此外,为了满足消费者对更清洁、更透明的成分錶的需求,有机和非基因改造配方的开发预计将获得推动。此外,与医疗保健提供者和医疗组织的合作将加强先进营养解决方案的采用和实施,帮助公司在要求创新和法规遵循的市场中保持竞争力。这些策略将使肠内营养市场领导者保持优势,同时透过改善患者治疗效果和扩大全球影响力来推动市场成长。
The enteral feeding formulas market encompasses a range of nutritional solutions administered to patients via the gastrointestinal tract when oral intake is inadequate, impossible, or unsafe. This method of feeding is used across various healthcare settings including hospitals, long-term care facilities, and home care. Enteral feeding is a vital component of clinical nutrition, especially for patients suffering from chronic diseases, those undergoing surgery, or individuals with malnutrition issues. The market for these formulas is driven by the rising prevalence of chronic diseases, advancements in formula compositions, and the increasing global elderly population. The enteral feeding formulas market is expected to grow at a CAGR of 7.2% during the forecast period of 2024 to 2032.
Drivers of the Enteral Feeding Formulas Market
Rising Incidence of Chronic Diseases and Malnutrition
The increasing prevalence of chronic diseases such as cancer, diabetes, and neurological disorders where patients often experience difficulty in maintaining adequate oral intake is a primary driver for the enteral feeding formulas market. The enhanced nutrition provided by these formulas helps manage disease symptoms, supports recovery, and improves the overall quality of life for patients. Hospitals and long-term care facilities are increasingly adopting enteral nutrition as a standard care practice for managing malnutrition and disease-related wasting, further propelling the demand for these products.
Technological Advancements in Feeding Formulas and Equipment
Significant technological advancements in the formulation and delivery of enteral feeding products have expanded their use and efficiency. The development of disease-specific formulas, which cater to the unique nutritional needs of patients with specific conditions like renal failure or pulmonary disorders, has enhanced patient outcomes and compliance with nutritional therapies. Innovations in feeding delivery systems, such as programmable pumps that ensure precise and safe feeding, have also contributed to market growth. These technological enhancements improve the palatability, absorption, and efficacy of feeding formulas, increasing their adoption across various medical and home care settings.
Aging Global Population
The global increase in the elderly population, who are more prone to chronic conditions and dysphagia (difficulty in swallowing), significantly drives the demand for enteral feeding formulas. Elderly patients often require long-term nutritional management to maintain their health and manage age-related physiological changes. The ease of use and the ability to administer these formulas at home have made enteral nutrition a preferred choice for geriatric care, supporting sustained growth in this segment of the market.
Restraint of the Enteral Feeding Formulas Market
Complications Associated with Enteral Feeding
Despite the benefits, the enteral feeding formulas market faces significant restraints due to the complications associated with tube feeding. Issues such as tube dislodgment, infections, and gastrointestinal complications like diarrhea and constipation can deter the use of enteral feeding. These complications require careful monitoring and management, adding to the overall healthcare costs and burden on providers and caregivers. The risk of aspiration and resultant pneumonia also poses a serious health risk, particularly in elderly and severely ill patients. This challenge impacts the adoption rates of enteral feeding among healthcare providers who must balance the benefits of enteral nutrition with the potential for adverse effects. The complexity of managing these risks, coupled with the need for specialized training for caregivers and healthcare professionals in tube feeding techniques, somewhat limits the market's growth potential.
Market Segmentation by Product
The enteral feeding formulas market is segmented by product into standard formulas, disease-specific formulas, elemental formulas, semi-elemental formulas, and other formulas. Disease-specific formulas are projected to exhibit the highest Compound Annual Growth Rate (CAGR) due to their targeted approach in managing specific clinical conditions such as renal disease, respiratory disease, or diabetes. These formulas are designed to meet the unique nutritional requirements and restrictions of these conditions, enhancing patient outcomes and compliance. On the other hand, standard formulas are anticipated to generate the highest revenue within the market. These formulas are broadly used due to their general application in providing balanced nutrition for patients without specific dietary restrictions or specialized nutritional needs. Standard formulas are a fundamental part of enteral nutrition across various healthcare settings, from hospitals to home care, making them a staple product in the enteral feeding industry. Their widespread use and the growing acceptance of enteral nutrition as a part of routine clinical care drive substantial revenues in this segment.
Market Segmentation by Stage
In the enteral feeding formulas market, segmentation by stage includes adults and pediatric patients. The pediatric segment is expected to experience the highest CAGR owing to the critical need for adequate nutrition in early development stages and the rising incidence of pediatric diseases and disorders that impair oral intake, such as failure to thrive, cerebral palsy, and cystic fibrosis. Pediatric formulas are specially designed to meet the nutritional needs of children, considering their growth requirements and metabolic rates. In contrast, the adult segment accounts for the highest revenue due to the larger volume of adult patients requiring enteral nutrition. This includes elderly patients with chronic illnesses or those undergoing recovery from surgery, as well as adults with disabilities or those receiving palliative care. The adult segment's dominance in revenue is supported by the increasing aging population globally and the prevalence of chronic diseases that necessitate long-term nutritional management, ensuring sustained demand for adult-specific enteral feeding formulas.
Geographic Segment in the Enteral Feeding Formulas Market
Within the enteral feeding formulas market, geographic trends reveal that North America currently leads in terms of revenue, bolstered by advanced healthcare infrastructure, high healthcare spending, and a growing prevalence of chronic diseases that require clinical nutrition solutions. Additionally, the region's stringent regulatory standards and high awareness about the benefits of enteral nutrition sustain its market dominance. Meanwhile, Asia-Pacific is expected to exhibit the highest Compound Annual Growth Rate (CAGR) from 2024 to 2032. This surge is driven by the increasing elderly population, particularly in countries like Japan and China, alongside rising healthcare expenditures and improving healthcare infrastructure. The expansion of hospitals and the increasing prevalence of diseases requiring nutritional management in these regions are also crucial factors accelerating market growth. Furthermore, government initiatives aiming to improve patient outcomes and the growing adoption of home healthcare services are amplifying the demand for enteral feeding solutions in Asia-Pacific, making it a rapidly expanding market within the global landscape.
Competitive Trends in the Enteral Feeding Formulas Market
The competitive landscape in the enteral feeding formulas market features prominent players such as Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Danone S.A., Fresenius Kabi, Functional Formularies, Hormel Health Labs, Kate Farms, Medtrition, Meiji Holdings, Nestle, NutriMedical, Real Food Blends, Vegenat Healthcare, and Victus. These companies have been instrumental in shaping the market dynamics through continuous innovation and strategic initiatives. In 2022, leading companies like Nestle and Abbott Laboratories reported robust revenues driven by their diversified product portfolios and strong global distribution networks. From 2024 to 2032, these key players are expected to focus on expanding their geographic presence and enhancing product offerings to meet the specific nutritional needs of a diverse patient population. Strategic mergers and acquisitions are anticipated to be prevalent as companies aim to broaden their capabilities and access emerging markets. Furthermore, investment in research and development is expected to increase, with a focus on creating more specialized and disease-specific formulas that cater to a range of medical conditions. The development of organic and non-GMO formulas is also anticipated to gain traction, responding to consumer demand for cleaner and more transparent ingredient lists. Additionally, collaborations with healthcare providers and institutions are likely to enhance the reach and implementation of advanced nutritional solutions, ensuring these companies maintain their competitive edge in a market driven by both innovation and regulatory compliance. Through these strategies, the top companies in the enteral feeding formulas market are set to continue their dominance while fostering market growth through enhanced patient outcomes and expanded global reach.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Enteral Feeding Formulas market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Enteral Feeding Formulas market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.